Professor Elinor Sawyer is looking for new ways to tell which lobular breast cancer patients may benefit from personalised therapies. She believes the environment within and around the tumour may hold a clue.
Professor Ross Chapman’s project will help us better understand how changes in the BRCA1 gene make breast cancer more likely. It’ll also help unpick why some breast cancer cells develop resistance to PARP inhibitor drugs.
Professor Anna Gavin aims to improve care for breast cancer patients by documenting the impact of the COVID-19 pandemic on their care and identifying areas where improvements can be made now and in the future.
Professor Ian Kunkler is investigating the impact that an additional, targeted booster dose of radiotherapy has on preventing DCIS from returning and developing into invasive breast cancer, and the effects it has on breast appearance and quality of life.